Expression profiles of nestin and synemin in reactive astrocytes and Müller cells following retinal injury: a comparison with glial fibrillar acidic protein and vimentin by Luna, Gabriel et al.
Expression profiles of nestin and synemin in reactive astrocytes and
Müller cells following retinal injury: a comparison with glial
fibrillar acidic protein and vimentin
Gabriel Luna,1 Geoffrey P. Lewis,1 Christopher D. Banna,1 Omar Skalli,3 Steven K. Fisher1,2
1Neuroscience Research Institute, University of California Santa Barbara, Santa Barbara, CA; 2Department of Molecular, Cellular,
and Developmental Biology, University of California Santa Barbara, Santa Barbara, CA; 3Department of Biological Sciences,
University of Memphis, Memphis TN
Purpose: To examine the expression patterns of the intermediate filament (IF) proteins nestin and synemin following
retinal injury.
Methods: Wide-scale retinal injuries were created by experimental retinal detachment of 1, 3, 7, or 30 days’ duration.
Injuries were induced in the right eyes of Long Evans rats, while the left eyes served as internal controls. Vibratome
sections of control and injured retinas were labeled with fluorescent probes using a combination of anti–glial fibrillary
acidic protein, -vimentin, -nestin, -synemin, -bromodeoxyuridine, and the lectin probe, isolectin B4. Additionally, antibody
specificity, as well as protein and mRNA levels of nestin and synemin were determined and quantified using standard
western blotting and real time polymerase chain reaction (RT–PCR) techniques.
Results: Immunocytochemistry showed increased Müller cell labeling at 1, 3, and 7 days post injury for all four IFs,
although  the  relative  levels  of  nestin  expression  varied  dramatically  between  individual  Müller  cells.  Nestin  was
consistently observed in the foremost processes of those Müller cells that grew into the subretinal space, forming glial
scars. Elevated levels of nestin expression were also observed in bromodeoxyuridine-labeled Müller cells following retinal
insult. Quantitative polymerase chain reaction (qPCR) showed a twofold increase in nestin mRNA 1 day after injury, a
level maintained at 3 and 7 days. Western blotting using anti-nestin showed a single band at 220 kDa and the intensity of
this band increased following injury. Anti-synemin labeling of control retinas revealed faint labeling of astrocytes; this
increased after injury, demonstrating an association with blood vessels. Additionally, there was an upregulation of synemin
in Müller cells. qPCR and western blotting with anti-synemin showed a continuous increase in both gene and protein
expression over time.
Conclusions: Retinal injury induces an upregulation of a complement of four intermediate filament proteins, including
synemin and nestin, in Müller cells. The latter provides suggestive support for the concept that these cells may revert to
a more developmentally immature state, since these two IF proteins are developmentally regulated and expressed, and
thus may serve as cell cycle reentry markers. Nestin and its differential expression patterns with glial fibrillary acidic
protein and vimentin networks, as well as its association with proliferating Müller cells and those extending into the
subretinal space, suggest a significant role of this protein in glial scar formation and perhaps gliogenesis. Synemin
immunopositive astrocytes demonstrate a close relationship to the retinal vasculature, and illustrate a remarkable ability
to reorganize their morphology in response to injury. Further examination of the changes in the cytoskeletal signatures of
both of these glial cell types may lead to a more comprehensive understanding of mechanisms underway following retinal
and other central nervous system injuries.
Intermediate filaments (IF) are abundant and dynamic
cytoskeletal  components  in  eukaryotic  cells  [1].
Approximately  70  genes  encode  eukaryotic  IF  proteins,
ranking this protein family among the largest in humans [2,
3]. Structurally, all members of this family contain a non-α-
helical N-terminal head and a C-terminal tail domain flanking
a central rod domain [4,5]. A common feature of all IF proteins
is their ability to form homo- or heteropolymers, a physical
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property  that  results  in  a  large  number  of  IF  protein
partnerships [6]. In general, IF proteins are expressed in a
cell-, tissue-, and developmentally specific manner, thereby
creating a “cytoskeletal fingerprint” that can provide insight
into cellular dynamics, such as differentiation, reactivity, or
the mitotic state [7].
Synemin and nestin are developmentally regulated IF
proteins that are expressed in undifferentiated astrocytes, as
well as in a subset of cortical glia [8]. Synemin, also known
as desmuslin, has two unique features: the occurrence of three
splice variants (H, M, and L), and the capacity to interact with
actin-associated proteins [9–11]. The major developmental
cytoskeletal protein nestin is also expressed during neural
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2511development, but is ultimately downregulated and replaced
by glial fibrillary acidic protein (GFAP) in astrocytes and
vimentin in Müller cells, the specialized radial glial cells of
the retina.
In  the  vertebrate  retina,  Müller’s  glia  account  for
approximately 90% of the glial population [12] and exhibit a
complex  structural  architecture  spanning  the  entire  retina
from  the  nerve  fiber  layer  (NFL)  to  the  base  of  the
photoreceptor  inner  segments.  Retinal  astrocytes  are  only
found in the NFL and account for 10% of the glial population.
Together, astrocytes and Müller cells perform a multitude of
developmental  and  physiologic  functions,  including
supplying  metabolic  support  by  means  of  glutamine  and
taurine in the normal retina [13], maintaining K+, H+, and
water balance, protecting against oxidative stress, recycling
cone  photopigments,  releasing  neuro-  and  vasoactive
substances,  and  serving  as  scaffolds  for  neurovascular
guidance [14,15]. Under normal conditions, rodent retinal
Müller cells predominately express vimentin. After injury,
however, they undergo a rapid change in the composition of
their cytoskeleton with the upregulation of both vimentin and
GFAP, a response indicative of a state of reactivity [16,17].
Collectively, Müller cells and astrocytes comprise the
intricate glial network of the retina [18], and both have been
shown to have similarities to glia in other parts of the central
nervous system (CNS) [19–21]. The cellular blueprint of both
retinal astrocytes and Müller cells creates a complex ordered
grid,  providing  essentially  complete  glial  coverage  of  the
entire neural retina. However, unlike Müller cells, which span
several retinal layers, astrocytes reside only in the innermost
layer of the retina, the NFL. In rodents, astrocytes arrive at
their  final  destination  during  development  by  migrating
through the optic nerve during the first postnatal week. In the
rat  retina,  astrocytes  demonstrate  fibrous  or  stellate
morphology,  possessing  a  highly  planar  appearance  in
contrast to the classical protoplasmic morphology of cortical
gray matter astrocytes [22]. Astrocytes also serve a vital role
in species that contain a vascular retina by secreting trophic
factors  such  as  vascular  endothelial  growth  factor,  which
permits and stimulates the formation of the retinal vascular
network [18].
After injury, Müller cells participate in a phenomenon
known  as  reactive  gliosis,  where  the  term  “reactive”
encompasses a wide range of molecular, biochemical, and
morphologic events. Anatomically, this process leads to an
increase in the size of Müller cells, as well as their growth out
of the neural retina, producing a scar that creates a physical
barrier between the retinal pigmented epithelium (RPE) and
photoreceptors,  ultimately  preventing  the  regeneration  of
damaged  photosensitive  outer  segments  following  retinal
reattachment [23]. Reactive gliosis is easily demonstrated by
immunocytochemistry  due  to  the  increased  expression  of
GFAP and vimentin in Müller cells [17,24]. Other Müller cell
responses to injury-induced retinal degeneration include the
induction of proliferation [25–27] and the downregulation of
specific enzymes and molecules vital to retinal homeostasis
such  as  glutamine  synthetase,  carbonic  anhydrase  C,  and
cellular retinaldehyde binding protein [28].
The dynamic relationship between IFs and retinal glia
may underscore a key mechanism in the rapid modification of
Müller cell structure in response to retinal injury or other
changes  in  the  retinal  milieu  [29].  Indeed,  in  GFAP-/-
vimentin-/- mice, Müller cells are unable to hypertrophy or
extend processes outside the neural retina following injury
[30]. In fact, studies of these mice suggest that the absence of
these two IF proteins may be neuroprotective following retinal
injury [31]. The goal of our study was to determine whether
the  two  developmentally  regulated  IF  proteins  nestin  and
synemin also show increased expression in the adult after
retinal injury, and if so, to determine their affiliation and
distribution within the retina relative to that of vimentin and
GFAP.
METHODS
Surgery: This study was conducted in accordance with the
NIH Animal Care and Use Committee protocols, the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research, as well as the guidelines of the Animal Resource
Center of the University of California Santa Barbara (Santa
Barbara, CA). Animals were housed in a 12 h light-dark cycle
and  were  provided  food  and  water  ad  libitum.  Using  an
operating microscope, retinal injuries were created in the right
eyes of Long Evans rats (Rattus norvegicus) as described in
detail elsewhere [28,30], while left eyes served as unoperated
controls in all procedures. In short, a small incision was made
to create a pilot hole through the sclera a few millimeters
below the limbus. A pulled glass micropipette (approximately
50 μm in diameter), under the control of a micromanipulator,
was inserted transvitreally between the neural retina and the
underlying RPE. A glass coverslip, placed on the cornea, was
used to enhance the visualization of the retina during this
procedure. Approximately 5 µl of solution containing Healon
(0.25% sodium hyaluronate; Pharmacia & Upjohn, Uppsala,
Sweden) diluted in balanced salt solution (BSS; Alcon, Ft.
Worth, TX) was infused between the neural retina and the
RPE, detaching approximately 75% of the retina. The Healon
was  necessary  to  prevent  the  retina  from  spontaneously
reattaching. No damage to the lens was observed at any time
during the surgery or during dissection of the eyes. Retinal
tissue  from  three  animals  per  experimental  group  was
harvested at 1, 3, 7, or 30 days following injury and processed
for immunocytochemistry, PCR, and western blotting. Three
additional  rats  were  given  an  intravitreal  injection  of
bromodeoxyuridine (BrdU; 10 µg in 10 µl of BSS; 4 h before
sacrifice at the 3 day time point; Sigma, St. Louis, MO).
Tissue  preparation  and  fixation:  Following  euthanasia,
globes  were  carefully  enucleated  and  immersion  fixed
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2512overnight  in  4%  paraformaldehyde  in  sodium  cacodylate
buffer (0.1 M; pH 7.4) at 4 °C. The following day, the cornea
and lens were dissected to form an eye cup in preparation for
agarose embedding and radial vibratome sectioning. Due to
the sensitivity of the synemin epitope to fixation, lightly fixed
cryosectioned tissue was needed. Here, eyes were excised as
described above; however, after 90 min of immersion fixation,
the cornea and lens were removed and the eye cup reimmersed
in fixative for 30 min.
Antibodies and immunocytochemistry (vibratome sections):
Immunocytochemical  experiments  were  performed  as
described previously [32]. Following fixation, rodent globes
were rinsed in PBS (pH 7.4) 3× for 15 min and once for 60
min, embedded in low-melt agarose (5%; Sigma) at 45 °C and
then  sectioned  at  100  μm  using  a  vibratome  (Leica,
Lumberton, NJ). For injured retinas, care was taken only to
sample those regions observed to be elevated from the RPE at
the time of enucleation. To prevent nonspecific binding of
antibodies,  retinal  sections  were  blocked  overnight  with
normal donkey serum 1:20 in PBS containing 0.5% BSA,
0.1% Triton X-100, and 0.1% Azide (PBTA) at 4 °C and
placed  on  a  rotator  for  continuous  agitation.  Primary
antibodies (Table 1), diluted in PBTA, were added to the
sections for another overnight incubation at 4 °C. The next
day retinal sections were rinsed in PBTA, 3× for 15 min and
once for 60 min, at which time the corresponding secondary
antibodies  (Table  1)  were  added  for  the  last  overnight
incubation at 4 °C. Finally, the sections were rinsed in PBTA
as  described  above,  mounted  in  5%  n-propyl  gallate  in
glycerol on glass slides, covered with a coverslip, and sealed
with  nail  polish.  Sections  labeled  with  BrdU  were
preincubated in 2N HCl for 1 h at 4 °C as an antigen retrieval
step then subsequently labeled using the above-mentioned
protocol.
Immunocytochemistry:  cryosections:  To  produce
cryosections, eye cups were rinsed 3× for 15 min in PBS and
then  cryoprotected  overnight  in  20%  sucrose  and  0.1  M
phosphate buffer in Optimal Cutting Temperature medium
(Electron Microscopy Sciences, Washington, PA), pH 7.4 at
4 °C. The next day, eyecups were embedded in 100% Optimal
Cutting Temperature and quickly immersed in liquid nitrogen;
20 µm thick sections were cut using a cryostat (Leica). After
collecting sections on a charged glass slide, sections were
blocked overnight in a humid chamber in normal donkey
serum diluted 1:20 in PBTA at room temperature. The next
day, without rinsing, primary antibodies (Table 1) diluted in
PBTA were added to the sections and incubated overnight.
Sections were then rinsed in PBTA 3× for 15 min and once
for 1 h, at which time they underwent a final incubation in a
solution of PBTA containing the appropriate combination of
secondary antibodies (Table 1) for 2 h at room temperature.
After rinsing in PBTA, sections were mounted and sealed as
described above.
Image acquisition: The specimens were viewed and images
collected  on  an  Olympus  FluoView  1000  laser  scanning
confocal microscope (Center Valley, PA) using an UPlanFLN
40× oil immersion lens, N.A. 1.30. Optical sections were
collected at 1 µm intervals and subsequently used to create
maximum  intensity  projections  using  Olympus  FluoView
viewer version 1.7a. Confocal images were collected at an
original  pixel  resolution  of  1024×1024.  Brightness  and
contrast levels were equally adjusted on all images using the
bio-image analysis software Mayachitra Imago version 1.0
(Santa Barbara, CA) or Adobe Photoshop CS3 software (San
Jose, CA).
Quantitative real time polymerase chain reaction: Real-time
(RT)–PCR was preformed as described in Radeke et al. [33].
To summarize, total RNA was isolated from rat tissue using
Qiagen  RNeasy  mini-preps  (Qiagen,  Valencia,  CA).  To
prevent  DNA  contamination,  a  DNA  digestion  step  was
included  using  RNase-free  DNase  (Ambion,  Austin,  TX).
Subsequently, RNA samples were repurified, and the quality
was  examined  by  microchannel  electrophoresis  using  an
Agilent Bioanalyzer (Agilent Technologies Inc., Palo Alto,
CA). Real-time quantitative PCR was performed using the
SYBR  Green  method  [34].  In  short,  primer  pairs  were
designed to generate a 100–200 base pair product from a
single site located no more than 600 base pairs away from the
polyadenylated tail of the mRNA (mRNA; Beacon Design
4.0; Premier Biosoft International, Palo Alto, CA).
TABLE 1. ANTIBODIES USED FOR THIS STUDY ALONG WITH THEIR SOURCE AND CONCENTRATIONS.
Antibody Species Form Dilution Manufacturer
anti-vimentin chicken polyclonal purified immunoglobulin 1:2000 Millipore, Temecula CA
anti-GFAP rabbit polyclonal purified immunoglobulin 1:400 DAKO, Carpenteria, CA
anti-nestin mouse monoclonal purified immunoglobulin 1:50 Millipore, Temecula CA
anti-synemin rabbit polyclonal affinity purified immunoglobulin 1:20 [38]
anti-BrdU rat monoclonal purified immunoglobulin 1:250 Accurate cheminal, Westbury, NY
isolectin B4 lectin biotinylated 1:50 Vector Labs, Burlingame, CA
Secondary
antibodies
Donkey anti-rabbit Cy5 purified antisera 1:200 Jackson Immuno Research, West Grove, PA
Donkey anti-mouse Cy3 purified antisera 1:200 Jackson Immuno Research, West Grove, PA
Donkey anti-chicken Cy2 purified antisera 1:200 Jackson Immuno Research, West Grove, PA
Donkey anti-rat Cy2 purified antisera 1:200 Jackson Immuno Research, West Grove, PA
Streptavidin Cy5 purified antisera 1:200 Jackson Immuno Research, West Grove, PA
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2513Using  the  iScript  cDNA  synthesis  kit  (Bio-Rad
Laboratories, Richmond, CA), 250 ng of RNA at each time
point were used to produce cDNA. Triplicate 20 µl PCR
reactions were set up using the following reaction settings:
50 mM KCl, 10 mM Tris-HCl (pH 9.0 at 25 °C), 2.5 mM
MgCl2,  0.1%  Triton  X-100,  0.2  mM  deoxynucleotide
triphosphate  (dNTPs),  0.20  units  of  Platinum  Taq  DNA
polymerase, 1× SYBR Green (Invitrogen Corp., Carlsbad,
CA), and 500 nM of sense and antisense gene-specific primers
(Operon,  Huntsville,  AL).  Amplification  of  cDNA  was
performed on a Bio-Rad MyIQ Single Color Real-Time PCR
detection system. The following temperature settings were
used to carry out RT–PCR: 3 min at 95 °C, then 45 cycles of
15 s at 93 °C, 10 s at 56 °C, 90 s at 72 °C, 20 s at 78 °C, and
20 s at 82 °C. Real-time fluorescence readings were measured
at 72 °C, 78 °C, and 82 °C. To decrease nonspecific signals
due  to  mispriming  or  primer-dimer  formation,  real-time
fluorescence measurements close to the melting temperature
of the amplicons were used for quantitative analysis. The
specificity  of  each  reaction  was  assessed  by  melting
temperatures  and  agarose  gel  electrophoresis  of  PCR
products. To control for differences in amounts of starting
material, the data were normalized to the geometric mean of
a set of “housekeeping” genes with expression levels that have
been  empirically  shown  not  to  change  as  a  function  of
location, age, or disease [35]. In this study, four housekeeping
genes were used to quantify levels of mRNA for genes of
interest (Table 2).
Western blots: Immunoblots were performed as described
elsewhere in detail [36]. In brief, after the careful dissection
of retinas from the eye cups, retinal tissue was flash frozen in
liquid nitrogen until all time point samples were collected.
Tissue was homogenized at 4 °C in cold PBS containing a
protease inhibitor cocktail (Roche, Palo Alto, CA). Tissue
lysates were then centrifuged at 11,000× g at 4 °C for 20 min,
after which soluble supernatant material was collected and
protein concentrations were determined using a DC protein
assay  kit  (Bio-Rad  Laboratories,  Richmond,  CA).  Equal
amounts  of  soluble  protein  were  loaded  into  7%
polyacrylamide resolving gels and subsequently run at 100V
for 90 min. Proteins were then electrophoretically transferred
to a nitrocellulose membrane in sodium bicarbonate (10 mM
NaHCO3, 3 mM Na2CO3, 10% methanol) buffer, blocked in
PBS  containing  5%  dry  nonfat  milk  and  0.1%  Tween-20
(blocking buffer) overnight at 4 °C. The following day, blots
were immunostained with primary antibodies, and diluted in
blocking buffer containing 0.1% Tween-20 overnight at 4 °C.
Blots were then rinsed 3× for 15 min in PBS and once for 1 h
in PBS containing 0.1% Tween-20 (rinse buffer); then they
were incubated in donkey anti-mouse, anti-chicken, or anti-
rabbit Alexa Fluor 680 nm or 800 nm conjugated secondary
antibodies (Molecular Probes, Eugene, OR) in blocking buffer
containing 0.1% Tween-20 for 1 h at room temperature. After
rinsing, blots were imaged using an Odyssey scanner (Li-Cor,
Lincoln, NE).
RESULTS
Müller  cell  responses:  nestin,  GFAP,  and  vimentin
expression: In control rat retinas, no specific nestin staining
was detected in any cell type, although blood vessels in the
outer  plexiform  layer  (OPL)  and  in  the  NFL  were
nonspecifically  immunolabeled  (Figure  1A,  red).  Control
staining with secondary antibodies alone showed that blood
vessel labeling in control tissue was due to the secondary anti-
rodent antibody recognizing IgGs in the blood vessels of the
rat retina (Figure 1B). Anti-GFAP labeled only astrocytes in
control retinas (Figure 1A; blue), while anti-vimentin labeled
Müller cells from their endfeet in the NFL to the level of
adherens  junctions  at  the  base  of  the  photoreceptor  inner
segments (outer limiting membrane, OLM; Figure 1A; green).
One  day  after  injury,  Müller  cells  displayed  a  dramatic
increase  in  immunofluorescence,  with  nestin,  GFAP,  and
vimentin labeling now extending from their endfeet in the
NFL to the OLM (Figure 1C-F). The fact that most Müller
TABLE 2. GENES AND THEIR PRIMER SEQUENCES USED FOR QUANTITATIVE PCR.
Gene name Gene symbol Accession number Primer sequence (5′-3′)
glial fibrillary acidic protein Gfap NM_017009 F: GAGTCCACAACCATCCTTCTGAG
  R: ACACCAGGCTGCTTGAACAC
vimentin Vim NM_031140 F: CTGCTGGAAGGGGAGGAGAG
  R: GGTCATCGTGGTGCTGAGAAG
nestin Nes NM_012987 F: GTCCTGGTTCCTGAACTTGTC
  R: GCTTCTTTCTCTACCAGTTCCC
synemin Synm NM_001134858 F: AAGAAAGCAGTT TGAACAGAAAG
  R: TGGTGATTCCAACTTAGAGATGAC
glyceraldehyde phosphate dehydrogenase Gapdh NM_017008 F: AAGTTCAACGGCAGTCAAG
  R: ACTCAGCACCAGCTCACC
glucose phosphate isomerase Gpi NM_207592 F: AGACCATCACCAACGCAGAG
  R: CCACCTACCCAATCCCAGAAC
TATA box binding protein Tbp NM_001004198 F: CAGTCCAATGATGCCTTACGG
  R: TGTTGCTGCTGCTGTTGC
ubiquitin C Ubc NM_017314 F: GACAGGCAAGACCATCACTC
  R: CCAAGAACAAGCACAAGAAGG
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2514cells produced yellow and orange signals 1 day after retinal
injury indicates the robust coexpression of nestin (red) and
vimentin (green) relative to GFAP (blue) at that time. Three
days after injury, however, a change in the combinatorial
expression profiles of IF proteins is evident in Müller cells,
reflecting the vigorous upregulation of GFAP. At this time
point, more Müller cells express increased levels of GFAP
(blue) and nestin (red), producing signals that appear more
pink or purple. In addition, nestin is expressed differentially
among individual Müller cells relative to vimentin and GFAP,
as  shown  by  the  resulting  myriad  of  color  combinations
(Figure 1C,G,H,I). Interestingly, 3 days following injury, anti-
nestin labeled rare complex processes in the ONL with the
appearance of microglial cells (Figure 1G,H arrows). At this
time, the initial stages of Müller cell growth into the subretinal
space were observed as small tapered angular processes tipped
with fine protuberances that were nestin positive (Figure 1I,
arrow).
To determine whether there was an association between
dividing Müller cells and IF protein expression, sections were
labeled with anti-BrdU at day 3, a time point previously shown
to be the peak of the proliferative response following retinal
detachment [25,26]. In control, noninjured retinas, no BrdU
labeling was observed; anti-GFAP labeled only astrocytes in
the  NFL,  while  the  only  apparent  anti-nestin  labeling
represents binding of the secondary antibody to blood vessels
(Figure  2A).  Three  days  after  injury,  and  4  h  after  an
intraocular injection of BrdU, BrdU-labeled Müller cell nuclei
were observed in the inner nuclear layer (Figure 2B). These
BrdU-labeled cells were consistently present in regions where
Müller  cells  extended  short  processes  beyond  the  OLM
(Figure 2C; arrows), and in regions with significant growth of
Müller cell processes into the subretinal space (Figure 2E,D;
arrows). At this time, anti-BrdU labeled nuclei were also
occasionally observed in astrocytes in the NFL (Figure 2D,F;
asterisks). These presumed astrocytes, however, were never
labeled with anti-nestin.
Müller cells and astrocytes: synemin expression: Control rat
retinas  displayed  low  levels  of  synemin  labeling  in
presumptive  horizontal  cells  in  the  OPL  (Figure  3A,C,
asterisk) and astrocytes in the NFL (Figure 3A, arrows). After
30  days  of  a  sustained  retinal  injury,  synemin
immunoreactivity  increased  in  Müller  cells  (Figure  3B,
arrows) and in the NFL. At this time point, synemin antibodies
labeled several Müller cells in a pattern similar to that for the
other three IF proteins, with labeling through the length of the
cell (Figure 3B-G), although this occurred with less frequency
among the Müller cells in comparison to GFAP. Synemin
labeling in the NFL of injured retinas that did not resemble
that of Müller cells was consistently associated with the retinal
vasculature, as identified by isolectin B4 labeling (Figure 3D-
G,  blue,  arrows).  These  synemin-labeled  processes  often
colocalized with anti-GFAP, and could be traced back to the
NFL. In addition, these processes tended to contact and wrap
blood  vessels  in  a  pattern  more  consistent  with  that  of
astrocytes than the “endfoot” type of contact made by the
lateral  processes  of  Müller  cells.  Interestingly,  a  small
subpopulation of Müller cells apparently express synemin
with  little  to  no  GFAP  expression  detected  (Figure  3F,
arrowheads),  once  again  demonstrating  the  phenotypic
diversity  of  Müller  cells  with  respect  to  changes  in  the
composition of their cytoskeleton as they respond to injury.
Real time polymerase chain reaction: nestin and synemin:
RT–PCR demonstrated that the gene expression levels for
nestin, GFAP, and vimentin all increased within a day after
injury and stayed elevated until the 7 day time point. Nestin
mRNA levels demonstrated an average twofold increase 7
days after injury (Figure 4A). Although immunocytochemical
data showed a clear increase in nestin expression, PCR data
showed an increase in mRNA levels at 1, 3, and 7 days with
only the last reaching statistical significance. In comparison,
RT–PCR data demonstrated that synemin mRNA levels were
not  statistically  significantly  different  from  those  of  the
control (Figure 4B) at all time points, although they increased
twofold at 7 days postinjury. This is in contrast to GFAP,
which shows a rapid increase at 1 day that is sustained at 3
and 7 days after injury (Figure 4C). The pattern of vimentin
mRNA in injured retinas compared to controls (Figure 4D)
showed  similar  trends  to  that  of  GFAP,  although  the
difference  did  not  reach  statistical  significance,  perhaps
because of the relatively high levels of vimentin found in
uninjured retinas.
Western blots: nestin and synemin: Western blotting detected
no nestin in the control retinas (Figure 5A), but faint bands
were observed at the 1 and 7 day time points. The single band
at approximately 250 kDa confirmed antibody specificity and
demonstrated  an  increase  from  control  retinas.  Western
blotting also showed an increase in both the H and M isoforms
of synemin protein after 7 days of injury (Figure 5B), with a
more dramatic increase in the H isoform.
DISCUSSION
In this study, we demonstrate that expression levels of the IF
protein synemin, in addition to GFAP, nestin, and vimentin,
are all elevated following retinal injury, and that nestin and
synemin may have functional significance in the remodeling
process of reactive glial cells. Nestin, GFAP, and vimentin IF
proteins are dramatically upregulated in Müller cells within a
day of retinal damage, but the levels of each vary considerably
among  individual  Müller  cells,  while  synemin  expression
remains low until at least the 7 day time point. Previous studies
have  shown  that  GFAP  expression  increases  greatly  after
retinal  injury  and  our  data  suggest  that  nestin  expression
undergoes  a  similarly  dramatic  increase  in  Müller  cells.
Indeed, nestin is the predominant IF protein expressed in
regions of BrdU labeled Müller cells, as well as in Müller cell
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2515Figure 1. Laser scanning confocal images of control and injured retinas labeled with antibodies to nestin, glial fibrillary acidic protein, and
vimentin. A, B: In the noninjured retina, glial fibrillary acidic protein (GFAP, blue) immunoreactivity is restricted to the very thin layer of
astrocytes in the nerve fiber layer (NFL). Apparent nestin labeling (red) in vascular structures is due to non-specific binding of the mouse
secondary IgG to rat blood vessels as demonstrated by the secondary control data in B. Anti-vimentin (green) labels all of the Müller cells
from the NFL into the outer nuclear layer (ONL). C: Following 1 day of injury these three intermediate filament proteins are greatly upregulated
with the labeling appearing as streaks extending across the retina. Note the heterogeneity of labeling patterns among Müller cells. D-F: Data
shown in C is divided into its three RGB channels to demonstrate the distinctive increases in anti-nestin (E) and anti-vimentin (F) labeling
relative to anti-GFAP (D). G, H, I: Three days following injury, the Müller cell labeling pattern appears distinctly different from those at 1
day as GFAP (blue) labeling increases, although the heterogeneity of intermediate filament protein labeling remains. Strongly nestin-positive
cells resembling microglial cells in the ONL occur at this time point (G, arrows), while Müller cells expressing predominately nestin begin
to show the formation of glial scars in the subretinal space (I, arrow). Scale bars represent 20 μm. OPL represents outer plexiform layer; OLM
represents outer limiting membrane.
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2516Figure 2. Laser scanning confocal images from control and injured retinas labeled with antibodies to nestin, bromodeoxyuridine and glial
fibrillary acidic protein. A: In control retinas, apparent anti-nestin labeling (red) due to nonspecific binding of the anti-mouse secondary
antibody (see Figure 1B) was observed outlining blood vessels in the outer plexiform layer, while anti-glial fibrillary acidic protein (GFAP,
blue) strongly labeled astrocytes in the nerve fiber layer (NFL). B-F: After 3 days of a sustained retinal injury, anti-nestin labeling is more
intense and more extensive in all Müller cells, but the degree of intensity varies across the retina as shown in figures B and D. Müller cell
nuclei that incorporate bromodeoxyuridine (BrdU, green) are associated with areas of strong anti-nestin labeling in both figures B and D.
Anti-nestin labeling of Müller cells is strongly associated with the presence of Müller cell outgrowth, whether at the earliest (C, arrows), or
at more advanced stages of glial scar formation (E, D). In some cases, anti-BrdU labeled nuclei were observed in anti-GFAP labeled cells in
the NFL indicating that astrocytic proliferation is also a component of the injury response (D, F, asterisks). In this study anti-nestin labeling
was not observed in astrocytes. Scale bars represent 20 μm. OLM represents outer limiting membrane; ONL represents outer nuclear layer;
OPL represents outer plexiform layer.
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2517Figure 3. Laser scanning confocal images illustrating immunoreactivity for synemin, glial fibrillary acidic protein, and the isolectin B4 labeling
in cryosections of control retina and following 30 days of injury. A: In control tissue, sparse synemin immunoreactivity (red) is present in
astrocytes of the nerve fiber layer (NFL; arrows), as well as in cells along the inner border of outer plexiform layer (OPL, asterisk), perhaps
representing the labeling of horizontal cells. B-G: After injury, anti-synemin labeling appears as vertical streaks across the retina representing
the processes of Müller cells (B, arrows) as well as more intense labeling of astrocytes extending processes laterally in the NFL (B). The triple-
labeled control retina shows the presence of anti-glial fibrillary acidic protein (GFAP, green) labeled astrocytes in the NFL, and an isolectin
B4-positive blood vessel (blue, arrow) coursing across the inner retina (C). Following long-term injury, many Müller cells express synemin
from the inner retina to the outer limiting membrane (OLM, D-G), although this population shows little overlap with radial processes expressing
GFAP at this time. Anti-synemin labeling also increased in astrocytes after injury, now extending into the outer retina but still associated with
retinal blood vessels (D-G, arrows). Scale bars represent 20 μm. ONL represents outer nuclear layer; OPL represents outer plexiform layer.
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2518processes  extending  outside  of  the  neural  retina.  While
synemin is also upregulated in Müller cells after injury, its
increase in expression is the least dramatic of the four IF
proteins  studied  here.  Interestingly,  in  contrast  to  nestin,
Figure  4.  Real-time  quantitative  PCR
gene expression analysis for control (left
eyes,  white  bars)  and  injured  retinas
(right eyes, black bars). For each graph,
the levels of gene expression for nestin
(A), synemin (B), glial fibrillary acidic
protein (GFAP; C), and vimentin (D)
were  normalized  relative  to  the
geometric  mean  of  the  four
housekeeping  genes:  glyceraldehyde
phosphate  dehydrogenase,  glucose
phosphate  isomerase,  TATA  box
binding  protein,  and  ubiquitin  C.  In
general, mRNA levels were elevated at
all injury time points. The p value shown
for the average data was computed using
a paired two-tailed Student t test (n=3).
In this study, values of 0.01 or higher
were considered statistically significant.
Error  bars  denote  standard  deviations
(SD).
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2519synemin  is  starkly  upregulated  by  retinal  astrocytes  in
response to injury; these cells develop long processes that
extend from the NFL into the outer retina and that maintain a
close  association  with  blood  vessels.  Altogether,  our
observations indicate that in response to retinal injury, both
nestin and synemin expression mirrors that of GFAP; all three
are upregulated in Müller cells, and synemin is expressed by
astrocytes  as  well.  To  our  knowledge,  this  is  the  first
demonstration that synemin is an indicator of reactivity to
injury by retinal astrocytes. In fact, by comparison to Müller
cell  reactivity,  astrocyte  reactivity  has  not  been  well
characterized  in  the  retina,  probably  because  structural
changes in astrocytes are greatly overshadowed by the larger
and more abundant changes found in Müller cells.
Tawk et al. [37] have shown the presence of synemin in
Müller cell endfeet in normal and diseased human retinas, as
well as in some neuronal processes in the inner nuclear layer.
However, our observations strongly suggest that astrocyte
labeling accounts for the synemin signal observed in the NFL.
Nonetheless, our results and those of Tawk et al. [37] both
demonstrate the presence of synemin in the Müller cells of
injured and diseased retinas, in our case in an experimental
model of retinal injury and in theirs in retinas from patients
with Merkel’s syndrome.
While synemin is not present in normal mature astrocytes,
it  has  been  demonstrated  in  human  reactive  astrocytes  in
various diseases [38]. Histological preparations of cortical
tissue have shown that anti-synemin labels reactive astrocytes
Figure  5.  Immunoblot  data  for  nestin
and synemin. A: Very faint bands of
nestin  were  visible  at  1  day  and  this
increased  at  7  days;  no  band  was
observed in control retinas (250 kDa).
Only  one  band  at  the  appropriate
molecular  weight  for  nestin  was
observed,  confirming  antibody
specificity.  Lightly  labeled  synemin
bands appeared in control tissue with a
steady increase between 1 and 3 days of
injury and a strong increase by 7 days
(arrows).  B:  Two  primary  bands
(arrows)  were  detected  for  synemin,
corresponding  to  the  presence  and
specificity of the antibody for both the
H and M isoforms (225 kDa, 175 kDa).
The  internal  control  glyceraldehyde
phosphate dehydrogenase (35 kDa) was
used to ensure equal protein loading.
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2520in wild-type mice after entorhinal cortical lesioning, but not
in GFAP and vimentin null mice [39]. Synemin was also
absent  in  vimentin  null  mice,  suggesting  that  vimentin  is
essential for synemin to accumulate at the protein level. GFAP
and vimentin have long been known to be present in astrocytes
throughout the course of development, but it is now realized
that these cells also produce synemin and nestin en route to
becoming mature glial cells [8]. In this context, our finding
that following retinal injury Müller cells reexpressing both
synemin and nestin also incorporate BrdU suggests that they
may  be  reverting  to  an  earlier  developmental  phenotype
compared  to  the  quiescent  Müller  cells  found  in  normal
retinas. Furthermore, the reexpression of nestin and synemin
may be important for the proliferation of Müller cells in the
injured retina, since nestin has been shown to facilitate the
mitotic disassembly of the IF network [40], and has also been
proved  to  be  a  positive  regulator  of  astrocytoma  cell
proliferation [41]. In a companion study however, we could
obtain no positive evidence for the dedifferentiation of mitotic
Müller cells after injury using a variety of accepted progenitor
markers  [27].  Thus,  the  question  of  Müller  cell
dedifferentiation after retinal injury in mammals has not been
conclusively answered.
Another discovery revealed by our immunocytochemical
data  is the striking  variability among individual Müller cells
with respect to their expression of various combinations of IF
proteins.  Although  the  functional  significance  of  this
variability is currently unknown, it was consistently observed
from 1 day of injury. Müller cell reactivity following injury
or  disease  has  long  been  known  [42–44],  but  the  data
presented here demonstrate additional features of the retina’s
response to injury. First, Müller cells display cytoskeletal
changes more diverse and complex than previously thought;
second,  our  data  demonstrate  significant  retinal  astrocyte
reactivity  in  response  to  trauma.  These  complex  changes
within Müller cells probably allow for the dramatic structural
remodeling that occurs in these large, elaborate radial glia as
they hypertrophy within the retina and form glial scars on
retinal cell surfaces. Therefore, changes in the composition of
the IF proteins may also be functionally associated with the
reentry of many of these cells into the cell cycle, especially
given the association between increased nestin expression and
BrdU incorporation.
Previous studies have demonstrated that the absence of
GFAP and vimentin greatly reduces the formation of glial
scars elsewhere in the CNS, as well as in the retina [30,45].
As elsewhere in the CNS, rapid changes in retinal glial cells
may have both beneficial and detrimental effects on the return
of function, a subject that remains controversial. Certainly,
glial  scar  tissue  formed  by  Müller  cells  can  thwart
photoreceptor  outer  segment  regeneration  [23]  or  become
contractile, causing wrinkling or even reinjuring the retina by
subsequently causing its separation from the RPE. However,
the overall effect of glial reactivity on retinal healing after
injury is in need of additional studies.
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